A coding IRAK2 variant compromises TLR signaling and is associated with colorectal cancer survival.
(2014) In Journal of Biological Chemistry 289(33). p.23123-23131- Abstract
- Within innate immune signaling pathways, Interleukin-1 receptor (IL-1R&)-associated kinases (IRAKs) fulfill key roles downstream of multiple Toll-like receptors (TLR) and the IL-1R. Whereas human IRAK4-deficiency was shown to lead to severe immunodeficiency in response to pyogenic bacterial infection during childhood, little is known about the role of human IRAK2. We here identified a non-synonymous IRAK2 variant, rs35060588 (coding R214G), as hypofunctional in terms of NF-κB signaling and TLR-mediated cytokine induction. This was due to reduced ubiquitination of TRAF6, a key step in signal transduction. IRAK2 rs35060588 occurs in 3-9% of individuals in different ethnic groups and our studies uncovered a significant genetic association... (More)
- Within innate immune signaling pathways, Interleukin-1 receptor (IL-1R&)-associated kinases (IRAKs) fulfill key roles downstream of multiple Toll-like receptors (TLR) and the IL-1R. Whereas human IRAK4-deficiency was shown to lead to severe immunodeficiency in response to pyogenic bacterial infection during childhood, little is known about the role of human IRAK2. We here identified a non-synonymous IRAK2 variant, rs35060588 (coding R214G), as hypofunctional in terms of NF-κB signaling and TLR-mediated cytokine induction. This was due to reduced ubiquitination of TRAF6, a key step in signal transduction. IRAK2 rs35060588 occurs in 3-9% of individuals in different ethnic groups and our studies uncovered a significant genetic association of rs35060588 with colorectal cancer survival. This for the first time firmly implicates human IRAK2 in human disease and highlights the R214G IRAK2 variant as a potential novel and broadly applicable biomarker for disease or as a therapeutic intervention point. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4523718
- author
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Biological Chemistry
- volume
- 289
- issue
- 33
- pages
- 23123 - 23131
- publisher
- American Society for Biochemistry and Molecular Biology
- external identifiers
-
- pmid:24973222
- wos:000341017200049
- scopus:84905981869
- pmid:24973222
- ISSN
- 1083-351X
- DOI
- 10.1074/jbc.M113.492934
- language
- English
- LU publication?
- yes
- id
- 18c52331-d4ae-4ccc-8ce9-1dc8bb8463e6 (old id 4523718)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/24973222?dopt=Abstract
- date added to LUP
- 2016-04-01 10:32:34
- date last changed
- 2022-01-26 00:16:56
@article{18c52331-d4ae-4ccc-8ce9-1dc8bb8463e6, abstract = {{Within innate immune signaling pathways, Interleukin-1 receptor (IL-1R&)-associated kinases (IRAKs) fulfill key roles downstream of multiple Toll-like receptors (TLR) and the IL-1R. Whereas human IRAK4-deficiency was shown to lead to severe immunodeficiency in response to pyogenic bacterial infection during childhood, little is known about the role of human IRAK2. We here identified a non-synonymous IRAK2 variant, rs35060588 (coding R214G), as hypofunctional in terms of NF-κB signaling and TLR-mediated cytokine induction. This was due to reduced ubiquitination of TRAF6, a key step in signal transduction. IRAK2 rs35060588 occurs in 3-9% of individuals in different ethnic groups and our studies uncovered a significant genetic association of rs35060588 with colorectal cancer survival. This for the first time firmly implicates human IRAK2 in human disease and highlights the R214G IRAK2 variant as a potential novel and broadly applicable biomarker for disease or as a therapeutic intervention point.}}, author = {{Wang, Hui and Flannery, Sinead M and Dickhöfer, Sabine and Huhn, Stefanie and George, Julie and Kubarenko, Andriy V and Lascorz, Jesus and Bevier, Melanie and Willemsen, Joschka and Pichulik, Tica and Schafmayer, Clemens and Binder, Marco and Manoury, Benedicte and Paludan, Søren R and Alarcon Riquelme, Marta and Bowie, Andrew G and Försti, Asta and Weber, Alexander N R}}, issn = {{1083-351X}}, language = {{eng}}, number = {{33}}, pages = {{23123--23131}}, publisher = {{American Society for Biochemistry and Molecular Biology}}, series = {{Journal of Biological Chemistry}}, title = {{A coding IRAK2 variant compromises TLR signaling and is associated with colorectal cancer survival.}}, url = {{http://dx.doi.org/10.1074/jbc.M113.492934}}, doi = {{10.1074/jbc.M113.492934}}, volume = {{289}}, year = {{2014}}, }